MACROH2A1 and cancer: Biased splicing towards the macroH2A1.2 isoform at the expense of macroH2A1.1 is reported in several cancer types [167,168,169,170], through downregulation of the QKI splicing factor [168], or through the activity of the DDX5 and DDX17 RNA helicases [167].